Compare Citius Pharmaceuticals Inc (CTXR) vs Danaos Corporation (DAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Danaos Corporation — how do they compare? Citius Pharmaceuticals Inc trades at $0.53 (market cap $14.64M), while Danaos Corporation trades at $129.89 (market cap $2.36B). The key difference: Danaos Corporation is far larger — about 161.2× Citius Pharmaceuticals Inc's market cap, and Danaos Corporation pays a 2.78% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | DAC | |
|---|---|---|
Market Cap | $14.64M | $2.36B |
Sector | Health | Technology |
52-Week High | $1.82 | $134.63 |
52-Week Low | $0.53 | $84.05 |
Enterprise Value | $10.86M | $2.36B |
Dividend Yield | — | 2.78% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Danaos Corporation
Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.
Read more on DAC →
